Bayer AG Enters Strategic Partnership With Medsintez-DJ


Friday, 2 Nov 2012 04:14am EDT 

Don Jones reported that Bayer AG announced that it has entered a strategic partnership with Medsintez for the production of pharmaceuticals in Russia. Bayer and Medsintez will jointly manufacture and commercialize diagnostic imaging products and pharmaceuticals to treat infections and neural disorders. In addition, the companies intend to cooperate in the research, development and production of new substances and medicines, aiming to accelerate the access to innovative pharmaceuticals for Russian patients. Joint marketing activities are scheduled to start in 2013. 

Company Quote

95.41
-2.28 -2.33%
15 Aug 2014